About Polyamyna
Polyamyna is a company based in St. John's (Canada) founded in 2017 by Kishan Gorityala and Ramesh Kumar Mani. Polyamyna has raised $353.92 thousand across 1 funding round. Polyamyna offers products and services including Keep Klear and MicroDome.
- Headquarter St. John's, Canada
- Founders Kishan Gorityala, Ramesh Kumar Mani
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Polyamyna Nanotech Private Limited
- Date of Incorporation 14 Jan, 2020
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$353.92 K (USD)
in 1 rounds
-
Latest Funding Round
$353.92 K (USD), Seed
Sep 05, 2023
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Polyamyna
Polyamyna offers a comprehensive portfolio of products and services, including Keep Klear and MicroDome.
A continuously active transparent coating is provided that offers a 7-day residual effect for combating infections
An antimicrobial additive is integrated into polymer matrices to enable the creation of enhanced products without altering existing processes
Funding Insights of Polyamyna
Polyamyna has successfully raised a total of $353.92K through 1 strategic funding round. The most recent funding activity was a Seed round of $353.92 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Polyamyna
Investment portfolio details for Polyamyna
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Polyamyna
Detailed financials for Polyamyna
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Polyamyna Comparisons
Peer comparison for Polyamyna
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Polyamyna
Detailed competitors of Polyamyna
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Polyamyna
Complete news archive for Polyamyna
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polyamyna
Polyamyna was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Polyamyna is headquartered in St. John's, Canada. It is registered at St. John's, Newfoundland And Labrador, Canada.
Polyamyna is a funded company, having raised a total of $353.92K across 1 funding round to date.
Polyamyna was founded in 2017 in St. Johns, Canada. Antimicrobial technologies are developed for healthcare, industrial, marine, defense, and aerospace sectors. Microbicidal coatings with extended effects, additives for polymers, and adjuvant antibiotic platforms are provided to address resistance and hospital infections. Antifouling coatings for marine settings and solutions for defense applications are also created. A diagnostic device for drug-resistant pathogens is under development.
Polyamyna offers Keep Klear and MicroDome.